Data / Form D filings / AdvanCell, Inc.
AdvanCell, Inc.: Form D filing
AdvanCell, Inc., a biotechnology company in Cambridge, MA, filed a Form D with the SEC in 2026. The latest, on July 16, 2026, reports $218.3 million sold of a $315 million offering to 41 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 245 MAIN STREET, Cambridge, MA, 02142
- Phone
- +64 22 799 1300
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2026
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2144758
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 16, 2026 | New notice | $315,000,000 | $218,333,294 | $96,666,706 | 41 | Jun 30, 2026 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Philina Lee | Executive Officer, Director | |
| Aaron Pickett | Executive Officer | |
| Wing Cheong Lam | Director | |
| Nik Economopoulos | Director | |
| Anthony Aiudi | Director | |
| Bali Muralidhar | Director | |
| Jamil Beg | Director | |
| Christopher Gagliardi | Director | |
| Andrew Adamovich | Director | |
| Andrew Kay | Director | |
| Kevin Cameron | Director |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of Jul 13, 2026 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what AdvanCell, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.